| Net (loss) income | -29.04M |
| Depreciation | 12.96M |
| Amortization of intangibles | |
| Amortization of deferred financing costs | |
| Change in deferred income tax | |
| Compensation under stock-based compensation plans | 3.35M |
| Loss on disposal of fixed assets | |
| Receivables, net of bad debt expense | 6.72M |
| Inventory | 12.8M |
| Prepaid expenses and other assets | 9.16M |
| Accounts payable | -31.25M |
| Claims payable | |
| Amounts due to plan sponsors | |
| Accrued interest | |
| Accrued expenses and other liabilities | |
| Net cash provided by (used in) operating activities | -38.54M |
| Purchases of property and equipment, net | |
| Cash consideration paid to CHS, net of cash acquired | |
| Net cash used in investing activities | -71.38M |
| Proceeds from new credit facility, net of fees paid to issuers | 84M |
| Borrowings on line of credit | |
| Repayments on line of credit | |
| Repayments of capital leases | -525K |
| Principal payments on CHS long-term debt, paid at closing | |
| Principal payments on long-term debt | |
| Deferred and other financing costs | 0 |
| Net proceeds from exercise of employee stock compensation plans | |
| Surrender of stock to satisfy minimum tax withholding | |
| Net cash (used in) provided by financing activities | 97.18M |
| Net change in cash and cash equivalents | -12.74M |
| Cash and cash equivalents - end of period | 15.58M |
| Cash and cash equivalents - end of period | 2.84M |
| Cash paid during the period for interest | 30.13M |
| Cash paid during the period for income taxes, net of refunds | 260K |